AROA BIOSURGERY LIMITED — Capital/Financing Update 2021

Jul 26, 2021

Market Announcement

==> picture [33 x 50] intentionally omitted <==

27 July 2021

==> picture [451 x 5] intentionally omitted <==

Aroa Biosurgery Limited (ASX: ARX) – Trading Halt

Description

The securities of Aroa Biosurgery Limited (‘ARX’) will be placed in trading halt at the request of ARX, pending it releasing an announcement. Unless ASX decides otherwise, the securities will remain in trading halt until the earlier of the commencement of normal trading on Thursday, 29 July 2021 or when the announcement is released to the market.

Issued by

Lisa Banh

Senior Adviser, Listings Compliance (Sydney)

Market Announcement 1/1 ASX Customer Service Centre 131 279 | asx.com.au

27 July 2021 ASX Limited

==> picture [113 x 52] intentionally omitted <==

27 July 2021

Corey Lian ASX Limited 20 Bridge Street SYDNEY NSW 2000

(By email: corey.lian@asx.com.au and tradinghaltssydney@asx.com.au)

REQUEST FOR TRADING HALT

Aroa Biosurgery Limited (ASX: ARX) (the Company ) requests an immediate halt to the trading of the Company’s securities (ASX: ARX) quoted on the Australian Securities Exchange ( ASX ) in accordance with ASX Listing Rule 17.1.

The trading halt is requested pending an announcement by the Company to the market regarding a capital raising ( Stated Purpose ).

In accordance with ASX Listing Rule 17.1, the Company provides the following information in relation to the request:

1. The trading halt is necessary to assist the Company in managing its continuous disclosure obligations prior to the Company making an announcement to the market in relation to the Stated Purpose above.

2. The Company requests that the trading halt remains in place until the earlier of commencement of normal trading on Thursday 29 July 2021, or when the announcement regarding the Stated Purpose is released to the market.

3. The Company expects to make the announcement to the market before the commencement of normal trading on Thursday 29 July 2021.

4. The Company is not aware of any reason why the trading halt should not be granted or of any further information necessary to inform the market about the trading halt.

Please contact me if you require any further information concerning this matter.

Yours sincerely, Aroa Biosurgery Limited

==> picture [113 x 41] intentionally omitted <==

Tracy Weimar Company Secretary

==> picture [273 x 33] intentionally omitted <==

AROA BIOSURGERY LIMITED ARBN 638 867 473 NZCN 1980577 64 Richard Pearse Drive, Auckland 2022, New Zealand AROABIO.COM